M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.89 USD -1.35% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MoonLake Immunotherapeutics
Cash from Investing Activities Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Cash from Investing Activities
-$25.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Cash from Investing Activities
-$3.2m
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Cash from Investing Activities
-CHf71.4m
CAGR 3-Years
-79%
CAGR 5-Years
3%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Cash from Investing Activities
-$467.8m
CAGR 3-Years
28%
CAGR 5-Years
-134%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Cash from Investing Activities
CHf68m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Cash from Investing Activities
-CHf1m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Cash from Investing Activities?
Cash from Investing Activities
-25.2m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Cash from Investing Activities amounts to -25.2m USD.

What is MoonLake Immunotherapeutics's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
22%

Over the last year, the Cash from Investing Activities growth was 22%.

Back to Top